The US Patent and Trademark Office and US Food and Drug Administration are working out how they will collaborate to promote greater access to medicines and increase competition. Industry representatives, patients, payors and other stakeholders will get a chance to provide feedback on potential actions the agencies may take to achieve this goal.
The agencies are holding a public “listening session” on 19 January to obtain input on their joint collaboration initiatives. The...







